SVP and Chief Technical Officer Michael J. Labarre sold $1.2M of Halozyme Therapeutics, Inc.

Sold$1,221,037

$42.56Price

28,689Shares

−19%Stake

What HALO did after the filing

Prices for HALO after this filing aren't in yet.

Traded Thu, Apr 1. Filed Thu, Apr 1, 3:44 PM ET, during the session. Not investment advice.